S100A9 and myelodysplastic syndrome: In another study, Chen et al. showed that the plasma concentration of S100A9 significantly increased in MDS patients and that, in a murine model of S100A9 expression, S100A9 drived expansion and activation of MDSC that contributed to cytopenia and myelodysplasia.